SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: F. Jay Abella, III who wrote (242)12/16/1997 9:59:00 AM
From: Paul S.  Read Replies (1) of 1185
 
I like the points that FJ makes! I too believe thta NRT is a great buy at this level. Take a look at the VSE Index it is currently below 600. This is just a market cycle that is bringing down the price of all stocks on the VSE, even the biotechs. I am expecting a turn around in the new year. I think that the value of NRT shares will dramatically increase when the markets turns for the simple fact that a large portion of their shares outstanding is now in the hands of the asian pharmaceutical co.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News